SciELO - Scientific Electronic Library Online

 
vol.117 número6Variables predictivas de talla baja adulta en pacientes con hipotiroidismo adquirido gravede origen autoinmuneSalud respiratoria y del sueño infantil tras una amniocentesis en el segundo trimestre índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Archivos argentinos de pediatría

versión impresa ISSN 0325-0075versión On-line ISSN 1668-3501

Arch. argent. pediatr. vol.117 no.6 Buenos Aires dic. 2019  Epub 01-Dic-2019

http://dx.doi.org/10.5546/aap.2019.397 

Brief reports

Neonatal pain and heart rate variability in preterm infants treated with surfactant: a pilot study

Nilufer Okura 

Nurdan Urasa 

Mehmet Buyuktiryakia 

Mehmet Y Oncelb 

Fatma N Saria 

Erbu Yarcia 

Evrim A Dizdara 

Fuat E Canpolata 

Serife S Oguza 

aDivision of Neonatology. Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey

bKatip Celebi University Faculty of Medicine, Neonatal Intensive Unit, Izmir, Turkey

ABSTRACT

Objective

We aimed to assess the pain perception of preterm infants treated with different surfactant administrationtechniques by using heart rate variability (HRV).

Methods

Preterm infants who required surfactant therapy for RDS were randomized to INSURE or MIST groups. HRV analysis was performed by Newborn Infant Parasympathetic Evaluation monitor. HRV was recorded before, during and aftersurfactant administration. Pain assessment was determined by Premature Infant Pain Profile (PIPP) score.

Results

Fourteen infants were enrolled in the study. Demographic characteristics of the groups were similar. PIPP scores did not differ between INSURE and MIST groups (p = 0.05). Statistically significant difference in median HRV during surfactant administration was observed between INSURE and MIST groups (52 vs. 56, p = 0.03). HRV analysiswas similar between groups before and after surfactantadministration.

Conclusion

Surfactant administration with MIST technique might be more comfortable for preterm infants with RDS. However further studies with larger series are needed.

Key words Intubation; Premature infant; Pain; Pulmonary surfactant

INTRODUCTION

Surfactant therapy is applied through two different techniques in order to treat respiratorydistress syndrome (RDS). The INSURE (intubate, surfactant, extubate) method is the most commonway for surfactant treatment.1 Recently, a newmethod, minimally invasive surfactant therapy (MIST), has been developed to administersurfactant. Surfactant administration via a thinendotracheal catheter during spontaneousbreathing with continuous positive airwaypressure (CPAP) has come into clinical use withthis method.2,5 However, not enough data andexperience exist on how MIST and INSURE techniques affect pain perception in newborns.

It is difficult to evaluate pain perception in infants. Presently, pain and/or discomfortassessment is mainly based on behavioral painscales. However, these scoring systems are basedon items like facial movements, body movements, or comfort ability and therefore subjected tosignificant inter- and intra-observer variability.6,9

Recent studies indicated that sympathetic and parasympathetic influences in response topainful or stressful stimulus can be measured byvariations of RR heart rate intervals. It has beenshown that the Newborn Infant Parasympathetic Evaluation (NIPE) index could assess theparasympathetic tone and evaluate prolongedpain, acute pain, discomfort, and comfortablestimulations. In this study, we aimed to comparethe pain perceptions of preterm infants treatedwith different surfactant administrationtechniques using heart rate variability (HRV) asmeasured by the NIPE index and PIPP score.

METHODS

This prospective randomized controlled study was conducted in the neonatal intensive care unit (NICU) of Zekai Tahir Burak Maternity Teaching Hospital between May and June 2015. Preterminfants with 26-32 weeks of gestational age and ≤1250 g birthweight who suffered from RDS wereenrolled. This trial was approved by the Zekai

Tahir Burak Maternity and Teaching Hospital Ethics Committee, and written parental consentwas obtained from the parents of each infant.

Preterm infants requiring surfactant therapy for RDS were randomly assigned to either INSURE or MIST groups when they wereadmitted to the NICU. NIPE monitor (Mdoloris Medical Systems, France) was attached toeach infant before surfactant administration. Infants with major congenital anomalies; PPV orintubation in the delivery room; structural cardiacanomalies; exposure to painful procedures likevenipuncture, suctioning, blood sampling, orheel prick 30 minutes before assessment; andlack of parental consent were excluded. RDS wasdiagnosed in infants exhibiting the followingsymptoms: need for supplemental oxygen, tachypnea, grunting, and intercostal retractions; it was confirmed by typical x-ray and bloodgas findings. A suggested protocol would be totreat infants ≤26 weeks' gestation when Fi O2requirements > 0.30 and infants >26 weeks' when Fi O2 requirements > 0.40.

Treatment strategies

Surfactant therapy via the MIST procedure was applied to the infants using a 5F, flexible, sterile nasogastric tube. Surfactant wasadministered in 1 bolus in 30 to 60 seconds andthe tracheal catheter was immediately withdrawn.

Infants who received surfactant via the INSURE technique were first orally intubatedwith a double-lumen endotracheal tube, and surfactant was instilled to the trachea in30 seconds. Manual lung inflation by a T-piecedevice at 20/5 cm H2O pressure was performedduring the surfactant instillation, and then theinfant was promptly extubated.

Poractant alfa (Curosurf; Chiesi Farmaceutici, Parma, Italy) was administered to all infants (200 mg/kg/dose for each patients) in thestudy. NIPE index of each infant was recordedconsecutively, before, during, and after surfactantadministration. The Premature Infant Pain Profile (PIPP) was used to measure behavioral andphysiological responses of infants to pain.10

Statistical analysis

Statistical analyses were performed using the statistical package SPSS for Windows v.17.0 (SPSS Inc., Chicago, Illinois). Normallydistributed data were given as mean and SD; others presented as median and range. Demographic percentage and mean outcomemeasures of patients were compared betweenthe two groups with Fisher's exact test, a chi-squared test, and a f-test. A p value of < 0.05 wasconsidered statistically significant.

The sample size was calculated using data derived from our NICU records from the prestudy period. Infants treated with surfactant hada NIPE index of 56 (geometric mean, log-normallydistributed) with a standard deviation of 9 duringthe pre-study period. To show a 30 % reductionin NIPE index with a two-sided a-error of 0.05and the p-error of 0.2, 14 infants were requiredfor randomization.

RESULTS

Fourteen infants were enrolled in the study: INSURE: n = 7; MIST: n = 7 (Figure 1). Mean ± SD) gestational age of the infants was 29.1 ± 1.5 inthe INSURE group and 29.4 ± 1.2 in the MIST group (p > 0.05). Mean (± SD) birthweights of theinfants were 1107 ± 103 g in the INSURE groupand 1127 ± 85 g in the MIST group (p > 0.05). Demographic characteristics of the groups wereshown in Table 1.

Figure 1 Flowchart of study infants 

Table 1 Demographic characteristics of the groups 

The PIPP scores and HRV variables of the groups are presented in Table 2. The median PIPP scores were 10 (10-13) and 10 (8-12) inthe INSURE and MIST groups, respectively. PIPP scores did not differ between infants inthe INSURE and MIST groups (p = 0.053). Astatistically significant difference in the median HRV of infants during surfactant administrationwas observed between the INSURE and MIST groups (52 vs. 56, p = 0.03). HRV analyses beforeand after surfactant administration were similarin both groups (Table 2). HRV index and PIPP score of each infant are shown in Table 3. Therewas a significant correlation between NIPE valuesand PIPP scores during surfactant administration (r2 = -0,811, p < 0.0001).

Table 2 Comparison of HRV index and PIPP scores 

Table 3 NIPE index and PIPP score of each infant 

DISCUSSION

In our study, we observed that the NIPE index was significantly higher during the surfactantadministration in infants treated with MIST technique and also correlated with PIPP scores.

There is consensus that the endotracheal intubation procedure should be performedwhile the infant is adequately sedated.10,11 However, there is ongoing debate about whetheror not sedation should be used during MIST, as the presence of spontaneous breathing is aprerequisite for the procedure. In the studiesevaluating MIST technique no sedation wasused.12 In our study we found that the MIST technique group had less pain compared to INSURE group. So, we suggested that surfactantadministration with the MIST technique, thus, may be more comfortable for preterm infantswith RDS.

Alexandre et al. compared HRV before and after standardized cocooning phases associatedwith the human voice and carried out: 1) bythe mother and 2) by a third person. HRV wasassessed and expressed as an index reflectingthe parasympathetic tone. They showed that cocooning associated with the human voice enhances HRV in the preterm infant, indicatingan increase in parasympathetic activity.13

Our study is strong in terms of revealing the stress levels of preterm infant treated withsurfactant. Pain was assessed by both the PIPP scores and NIPE index, while different surfactantadministration techniques were applied to theinfants. PIPP score is a powerful scale that hasbeen used in the objective assessment of painin premature infants. Scarce information isavailable in the literature about the pain sensationthat MIST practice can produce, and our trialpresents results that will help illuminate this areaof inquiry. In addition, current trial is the firststudy to compare PIPP score with NIPE index inpreterm infants.

Our study has some limitations. First, HRV is controlled by the autonomic nervous systemoutflow, which can be altered by numerousfactors, including maturation, environmentalconditions, and/or drugs. Second it is a smallsample sized study.

CONCLUSION

Our findings suggest that surfactant administration using the MIST technique mightbe more comfortable for preterm infants with RDS.

REFERENCIAS

1. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatmentduring continuous positive airway pressure. J Perinatol. 2007;27(7):422-7. [ Links ]

2. Göpel W, Kribs A, Ziegler A, Laux R, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): anopen-label, randomised, controlled trial. Lancet. 2011;378(9803):1627-34. [ Links ]

3. Kribs A, Vierzig A, Hünseler C, Eifinger F, et al. Early surfactant in spontaneously breathing with n CPAP in ELBW infants-a single centre of our year experience. Acta Paediatr. 2008;97(3):293-8. [ Links ]

4. Kribs A, Härtel C, Kattner E, Vochem M, et al. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr. 2010;222(1):13-7. [ Links ]

5. Kribs A, Pillekamp F, Hünseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing withn CPAP: feasibility and outcome in extremely premature infants (postmenstrual age </=27 weeks). Paediatr Anaesth. 2007; 17(4) :364-9. [ Links ]

6. Grunau RE, Oberlander T, Holsti L, Whitfield MF. Bedside application of the Neonatal Facial Coding System in painassessment of premature neonates. Pain. 1998;76(3):277-86. [ Links ]

7. Carbajal R, Paupe A, Hoenn E, Lenclen R, Olivier-Martin M. DAN: une échelle comportementale d'evaluation de la douleur aiguë du nouveauné. Arch Pediatr. 1997;4(7):623-8. [ Links ]

8. Stevens B, Johnston C, Petryshen P, Taddio A. Premature Infant Pain Profile: development and initial validation. Clin J Pain. 1996;12(1):13-22. [ Links ]

9. Logier R, De Jonckheere J, Delecroix M, Keribedj A, et al. Heart rate variability analysis for arterial hypertension etiological diagnosis during surgical procedures undertourniquet. Conf Proc IEEE Eng Med Biol Soc. 2011; 2011:3776-9. [ Links ]

10. Friesen RH, Honda AT, Thieme RE. Changes in anterior fontanel pressure in preterm neonates during trachealintubation. Anesth Analg. 1987;66(9):874-8. [ Links ]

11. Pokela ML, Koivisto M. Physiological changes, plasma beta-endorphin and cortisol responses to tracheal intubation in neonates. Acta Paediatr. 1994;83(2):151-6. [ Links ]

12. Dargaville PA, Aiyappan A, De Paoli AG, Kuschel CA, et al. Minimally-invasive surfactant therapy in preterminfants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed. 2013;98(2):F122-6. [ Links ]

13. Alexandre C, De Jonckheere J, Rakza T, Mur S, et al. Impact du cocooning et de la voix humaine sur le systéme nerveux autonome (SNA) de l'enfant grand prématuré. Arch Pediatr. 2013;20(9):963-8. [ Links ]

Received: July 9, 2018; Accepted: June 27, 2019

E-mail address: Nilufer Okur, M. D.: n.matur@hotmail.com

Conflict of interest

None.

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons